Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amyloid imaging: from benchtop to bedside.

Chunying Wu1, Victor W Pike, Yanming Wang

  • 1Department of Medicinal Chemistry, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA.

Current Topics in Developmental Biology
|December 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Triarylselenonium triflates provide efficient access to no-carrier-added <i>ortho</i>-, <i>meta</i>-, and <i>para</i>-[<sup>18</sup>F]Fluoroarenes.

Chemical science·2026
Same author

Deoxyradiofluorination of Phenols via a Difluoromethoxy Nucleofuge Enabled by Organic Photoredox Catalysis.

ACS central science·2026
Same author

Synthesis and Preclinical Evaluation of [<sup>11</sup>C]GNE-0877 as a Potential PET Radioligand for Imaging Brain Leucine-Rich Repeat Kinase 2.

ACS omega·2026
Same author

Subanesthetic doses of ketamine to rats and monkeys rapidly increases radioligand binding in brain to phosphodiesterase-4, an indirect marker of cAMP.

Translational psychiatry·2026
Same author

Corrigendum to 'Synthesis and investigation of substituted 1,5-diaryl-1H-1,2,4-triazoles for the discovery of <sup>18</sup>F-labeled probes for imaging brain cyclooxygenase-1' [Eur. J. Med. Chem. 2025, 118523].

European journal of medicinal chemistry·2026
Same author

Dynamic Contrast Enhanced-Magnetic Resonance Fingerprinting (DCE-MRF) Improves Detection of Induced Vascular Perfusion Reduction in a Mouse Breast Cancer Model.

Magnetic resonance in medicine·2026
Same journal

Building a resilient ovarian reserve: Early soma-oocyte interactions.

Current topics in developmental biology·2026
Same journal

Role of macrophages in testis function.

Current topics in developmental biology·2026
Same journal

Role of retinoic acid in meiosis.

Current topics in developmental biology·2026
Same journal

Impact of cancer immunotherapies on oocyte health and ovarian function.

Current topics in developmental biology·2026
Same journal

The ovarian stroma as a key regulator of follicular development and gamete quality across the reproductive lifespan.

Current topics in developmental biology·2026
Same journal

Intercellular cyclic nucleotide dynamics mediate oocyte meiosis in mammalian preovulatory follicles.

Current topics in developmental biology·2026
See all related articles

Researchers developed novel amyloid-imaging agents for Alzheimer's disease (AD). These agents enable in vivo detection and quantification of brain amyloid plaques, aiding diagnosis and drug development for AD and other neurodegenerative disorders.

Area of Science:

  • Neuroscience
  • Radiochemistry
  • Pharmacology

Background:

  • Alzheimer's disease (AD) therapies aim to halt or reverse amyloid plaque deposition.
  • In vivo detection and quantification of brain amyloid plaques are crucial for evaluating anti-amyloid therapies.
  • Positron emission tomography (PET) and single photon emission computed tomography (SPECT) are key in vivo imaging modalities.

Purpose of the Study:

  • To provide a comprehensive review of amyloid-imaging agent development.
  • To survey in vitro binding properties and in vivo pharmacokinetic profiles of reported agents.
  • To highlight the progress and potential applications of these agents in AD research.

Main Methods:

  • Focus on small-molecule probes derived from amyloid dyes (e.g., Congo red, thioflavin T).

Related Experiment Videos

  • Systematic investigation through structure-activity relationship studies.
  • Evaluation of lead compounds (PIB, FDDNP, SB-13) in human subjects.

    • Main Results:

    • Small-molecule probes demonstrate favorable properties for in vivo studies.
    • Three lead compounds (PIB, FDDNP, SB-13) were identified and evaluated in humans.
    • These compounds show characteristic retention in AD subjects, confirming in vivo detection of amyloid deposits.

    Conclusions:

    • Amyloid-imaging agents can be readily detected and quantified in vivo.
    • These agents show promise as biomarkers for early AD diagnosis and drug development.
    • Success in AD imaging agents facilitates development for other neurodegenerative disorders.